Search This Blog

Thursday, November 7, 2019

Meridian Bioscience EPS beats by $0.04, beats on revenue

Meridian Bioscience (NASDAQ:VIVO): Q3 Non-GAAP EPS of $0.13 beats by $0.04; GAAP EPS of $0.10 beats by $0.02.
Revenue of $50.8M (-4.3% Y/Y) beats by $0.23M.
Shares -3% PM.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)